2 options
Anti-obesity drug discovery and development. Volume 4 / edited by Atta-ur-Rehman.
- Format:
- Book
- Author/Creator:
- Rahman, Atta-ur, Author.
- Series:
- Anti-Obesity Drug Discovery and Development ; 4
- Language:
- English
- Subjects (All):
- Appetite depressants.
- Physical Description:
- 1 online resource (245 pages)
- Edition:
- 1st ed.
- Place of Publication:
- Sharjah, United Arab Emirates : Bentham Science Publishers, 2018.
- Summary:
- Obesity is a complex health problem, caused by a number of factors such as excessive food intake, lack of physical activity, genetic predisposition, endocrine disorders, medications and psychiatric illnesses. The incidence of obesity among populations in both the developing and the developed world has reached epidemic proportions. In response to this, efforts to control and treat obesity have also been vigorously pursued, ranging from activities focused on raising awareness about lifestyle changes to the discovery and development of safe and effective anti-obesity drugs. Anti-obesity Drug Discovery and Development is a book series focused on this very important area of healthcare research. Each volume presents insightful updates on pharmaceutical research and development for clinical researchers and healthcare professionals involved in obesity treatment programs. The fourth volume of this series is a compilation of 6 reviews on anti-obesity treatment strategies including updates on obesity and cancer prevention through dietary modulation, the role of anti-obesity medications in polycystic ovary syndrome, potential anti-obesity strategies targeting mitochondria, calcium silicate based formulations for anti-obesity therapy, and the identification of obesity medications from natural products and plants.
- Contents:
- Cover
- Title
- Biblography
- End User License Agreement
- Contents
- Preface
- List of Contributors
- Dietary Modulation, Obesity and Cancer Prevention
- Jennifer Man Fan Wan1,* and Hiu Yee Kwan2
- INTRODUCTION
- HOW DIET RELATES TO CANCERS?
- Dietary Factors that Promote the Cancer Initiation
- Ingestion of Powerful, Direct-Acting Carcinogens or their Precursors
- Ingestion of Carcinogens that are Produced via Food Processing
- Ingestion of Carcinogens Produced in Stored Food
- Formation of Carcinogens in the Body
- DIETARY FACTORS THAT PROMOTE THE CANCER DEVELOPMENT
- GENERAL MECHANISM OF HOW OBESITY CAN CAUSE AND PROMOTE CANCER
- DIETARY COMPONENTS WITH CANCER PREVENTION POTENTIAL
- DIETARY COMPONENTS THAT AFFECT BODY WEIGHT
- PROSPECTIVE FOR THE ANTI-CANCER STUDY
- SUMMARY
- ABBREVIATIONS
- CONSENT FOR PUBLICATION
- CONFLICT OF INTEREST
- ACKNOWLEDGEMENTS
- REFERENCES
- The Role of Anti-Obesity Medications in Polycystic Ovary Syndrome
- Ilgın Turkcuoglu1,* and Rauf Melekoglu2
- Orlistat, Sibutramine, and Rimonabant
- Insulin-sensitizing Drugs (Metformin, Rosiglitazone, Pioglitazone, and D-chiro-inositol)
- GLP-1 Agonists (Exenatide, Liraglutide), Phentermine and Topiramate
- Other Drugs
- Sirtuins and Bile Acids: Potential Anti-obesity Strategies Targeting Mitochondria
- João Alves Amorim1,#, João Soeiro Teodoro1,2,#, Carlos Marques Palmeira1,2 and Anabela Pinto Rolo1,2,*
- SIRTUIN ACTIVATORS AS A NOVEL ANTI-OBESITY STRATEGY
- Sirtuins
- Physiological Role of Sirtuins in Metabolism
- Physiological Role of Sirtuins and Obesity and Metabolic Syndrome
- Sirtuins Activators for Therapy
- Sirtuin Activators for Therapy in Obesity
- NAD+-boosting Compounds.
- BILE ACIDS, OBESITY AND MITOCHONDRIA
- Bile Acid Receptors Discovery and Properties
- BA Effects and Mitochondria
- CONCLUDING REMARKS
- Development and Characterization of Calcium Silicate Based Formulations for Anti-Obesity Therapy: Orlistat
- Sunil K. Jain*
- FLOATING MICROSPHERES
- Preparation of OT Absorbed CS
- Preparation of Floating Microspheres
- Characterization of Floating Microspheres
- Micromeritic Properties and Morphology
- Percentage Buoyancy and Drug Entrapment
- In vivo Drug Release of Floating Microspheres
- Gamma Scintigraphy
- Pharmacokinetic Studies
- FLOATING GRANULES
- Preparation of Floating Granules
- Characterization of Floating Granules
- Drug Content and Floating Ability
- In vitro Drug Release of Floating Granules
- CONCLUSION
- Multi Targeted Strategies Towards Identification of Potential Drug Candidates from Natural Products in the Management of Obesity
- Baddireddi Subhadra Lakshmi*, 1,2 and Gopal Thiyagarajan2
- CURRENT TREATMENT STRATEGIES FOR OBESITY
- MEDICINAL PLANTS AS A SOURCE FOR NOVEL DRUGS
- MECHANISM AND MOLECULAR TARGETS OF OBESITY
- INHIBITION OF LIPID ABSORPTION
- Pancreatic Lipase Inhibitors
- SUPPRESSION OF APPETITE
- Glucagon Like Peptide 1 Analogues and Dipeptidyl Peptidase 4 Inhibitors
- Cholecystokinin Agonists
- Neuropeptide Y Antagonist
- Leptin
- Protein Tyrosine Phosphatase 1B Inhibitors
- INHIBITION OF ADIPOGENESIS
- Peroxisome Proliferator Activated Receptor γ (PPARγ)
- Adiponectin
- Partial PPARγ Agonists
- ENERGY EXPENDITURE
- Thermogenesis
- MODULATION OF LIPID METABOLISM
- Lipolysis
- β-Oxidation
- Adenosine Monophosphate (AMP) Kinase Activators.
- Sirtuin 1 as a Novel Target of Obesity
- MULTIFUNCTIONAL ROLE OF NATURAL ANTIOBESITY COMPOUNDS
- CLINICAL TRIALS STUDY
- Anti-Obesity Molecules from Plants and their Mode of Action
- Megha Valsaraj, Navaneetha Saseendran, Arun Subash Koorapally and Anu Augustine*
- GENERAL INTRODUCTION
- Obesity
- Definition and Assessment of Obesity
- Genetic and Environmental Factors Causing Obesity
- Endocrine and Metabolic Factors
- Psychological Factors
- Control of Appetite and Energy Expenditure
- Obesity Management
- Role of Medicinal Plants in Obesity Treatment
- Mechanism of Action of Anti obesity Agents from Plants
- Modifying Serum Lipoprotein
- Modifying Serum Apolipoproteins
- Enzyme Inhibition
- Inhibitors of Adipogenesis and Adipogenic Factors
- Blocking Intestinal Absorption
- Appetite Suppressants
- Details of Plants Selected for Study
- Holoptelea Integrifolia
- Averrhoa bilimbi Linn.
- Terminalia chebula Retz.
- Acorus calamus Linn.
- Picrorhiza kurroa Royle ex Benth
- Experimental Model and Findings
- Methodology
- Animals
- Acute Oral Toxicity
- Establishment of Experimental Model
- Drug Treatment
- Effect of Plant Extracts on Serum Lipids
- Effect of Plant Extracts on HDL Cholesterol Levels
- Effect of Plant Extracts on LDL Cholesterol Levels
- Effect of Plant Extracts on Apolipoproteins
- Effect of Different Plant Extracts on Enzymes Involved in Cholesterol Pathway
- HMG-CoA Reductase
- Lecithin-Cholesterol Acyltransferase
- Lipoprotein Lipase
- Effect of Different Plant Extracts on Intestinal Fat Absorption
- Effect of Different Plant Extracts on Inhibition of Adipogenesis and Adipogenic Factors
- REFERENCES.
- Subject Index
- Back Cover.
- Notes:
- Description based on print version record.
- ISBN:
- 9781681085586
- 1681085585
- OCLC:
- 1159421134
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.